These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10198923)

  • 21. [Statins, life style and treatment of hypercholesterolemia: the time is changing, criteria too].
    Pintó X
    Med Clin (Barc); 2006 Feb; 126(6):217-9. PubMed ID: 16510095
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of cholesterol abnormalities.
    Lockman AR; Tribastone AD; Knight KV; Franko JP
    Am Fam Physician; 2005 Mar; 71(6):1137-42. PubMed ID: 15791891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significant decline in the rate of cardiovascular incidents].
    Wedekind S
    MMW Fortschr Med; 2015 Jun; 157(11):66. PubMed ID: 26049360
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.
    Armstrong DW; Brouillard D; Matangi MF
    Can J Cardiol; 2011; 27(2):167-70. PubMed ID: 21459264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of European guidelines: changing the management of cholesterol levels.
    Erhardt LR; Gotto A
    Atherosclerosis; 2006 Mar; 185(1):12-20. PubMed ID: 16309687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol alert.
    Smith IK
    Time; 2001 May; 157(21):90. PubMed ID: 11393039
    [No Abstract]   [Full Text] [Related]  

  • 27. Very low LDL-cholesterol concentrations achieved: which target is next?
    Hovingh GK; Boekholdt SM; Stroes ES
    Lancet; 2017 Oct; 390(10106):1930-1931. PubMed ID: 28859941
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid-lowering therapy and risk of coronary events.
    Mascitelli L; Pezzetta F
    JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709464
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statins--the panacea of the turn of the century?].
    Lubiszewska B; Ruzyłło W
    Pol Arch Med Wewn; 2004 May; 111(5):617-24. PubMed ID: 15508815
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
    Grundy SM; Cleeman JI; Rifkind BM; Kuller LH
    Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management.
    Zárate A; Manuel-Apolinar L; Saucedo R; Hernández-Valencia M; Basurto L
    Arch Med Res; 2016 Oct; 47(7):491-495. PubMed ID: 28262189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic.
    Kiburg KV; Ward GM; O'Neal DN; MacIsaac RJ
    Intern Med J; 2018 Feb; 48(2):201-204. PubMed ID: 29415350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol lowering in older patients.
    Bannerman KS
    Ann Intern Med; 1999 Jul; 131(2):155-6. PubMed ID: 10419438
    [No Abstract]   [Full Text] [Related]  

  • 35. Statins as cardioprotective agents.
    Piskur JR; Stone NJ
    Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study.
    Paragh G; Márk L; Zámolyi K; Pados G; Ofner P
    Clin Drug Investig; 2007; 27(9):647-60. PubMed ID: 17705573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 38. Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management.
    Johnston TP; Korolenko TA; Pirro M; Sahebkar A
    Pharmacol Res; 2017 Jun; 120():219-225. PubMed ID: 28408313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The other face of statins].
    Kaletha K; Chodorowski Z; Sein Anand J; Szydłowska M; Rybakowska I; Nagel-Starczynowska G
    Przegl Lek; 2002; 59(4-5):364-6. PubMed ID: 12184008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Limitations of interventions against hypercholesterolemia].
    Ripoll MA
    Aten Primaria; 1996 Mar; 17(4):305-6. PubMed ID: 8679872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.